Abstract
The aim of this chapter is to summarize the renal problems encountered in the management of adult genito-urinary cancers. Maintenance of renal function is crucial in the management of most malignancies including genitourinary cancer as optimal renal function is necessary for multimodal cancer therapy. There are a number of scenarios when either renal function is likely to be compromised as a result of cancer itself (e.g. Bilateral obstruction of ureters), treatment (following chemotherapy or surgery) and occasionally long time after the treatment (Retroperitoneal fibrosis).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bankir L, Trinh-Trang-Tan M-M. Urea and the kidney. In: Breener BM, editor. Brenner and Rector’s kidney. 6th ed. Philadelphia: WB Saunders; 2000. p. 637–79.
Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988;39:465–90.
Doolan PD, Alpen EL, Theil GB. A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med. 1962;32:65–79.
Levy AS, Madaio MP, Perrone RD. Laboratory assessment of renal disease: clearance, analysis and biopsy. In: Brenner BM, Rector FC, editors. The kidney. 4th ed. Philadelphia: WB Saunders; 1991. p. 919–68.
Position statement: chronic kidney disease and automatic reporting of estimated glomerular filtration rate. Med J Aust. 2005;183:138–41.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.
Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70.
Poole SG, Dooley MJ, Rischin D. A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99m DTPA clearance) in cancer patients. Ann Oncol. 2002;13:949–55.
Peters AM. Quantification of renal haemodynamics with radionuclides. Eur J Nucl Med. 1991;18(4):274–86.
NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation. Am J Kidney Dis. 1997;30(3 Suppl 2):S15–66.
Stahl RAK, Löw I, Schoeppe W. Progressive renal failure in a patient after one and two-thirds nephrectomy. J Mol Med. 1988;66:508–10.
Abdi R, Dong VM, Rubel JR, et al. Correlation between glomerular size and long-term renal function in patients with substantial loss of renal mass. J Urol. 2003;170(1):42–4.
Solomon R, Werner C, Mann D, D’Elia J, Silva P. Effects of saline, mannitol, and frusemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416–20.
Novick AC, Derweesh I. Open partial nephrectomy for renal tumours: current status. BJU Int. 2005;95 Suppl 2:35–40.
Novick AC. Renal hypothermia: in vivo and ex vivo. Urol Clin North Am. 1983;10:637–44.
Secin FP, Carver B, Kattan M, Eastham JA. Current recommendations for delaying renal transplantation after localizedprostate cancer treatment: are they still appropriate? Transplantation. 2004;78:710–2.
Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001;1 Suppl 2:3–95.
Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study – group of 3. Lancet. 1999;354:93–9.
Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol. 2003;14:197–207.
Doublet JD, Peraldi MN, Gattegno B, Thibault P, Sraer JD. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol. 1997;158(1):42–4.
Truong LD, Krishnan B, Cao JT, Barrios R, Suki WN. Renal neoplasm in acquired cystic disease. Am J Kidney Dis. 1995;26:1–12.
Bokemeyer C, Thon WF, Brunkhorst T, et al. High frequency of urothelial cancers in patients with kidney transplantations for end-stage analgesic nephropathy. Eur J Cancer. 1996;32A(1):175–6.
Weld JK, Landman J. Comparison of cryoablation, radiofrequency ablation, land HIFU for treating small renal tumours. BJU Int. 2005;96:1224–9.
Darmon M, Ciroldi M, Thiery G, et al. Clinical review: specific aspects of acute renal failure in cancer patients. Crit Care. 2006;10:211 (Epub: Published ahead of print).
Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Ann Rev Pharmacol Toxicol. 1993;32:4350–65.
Gutthann SP, Rodriguez LAG, Raiford DS, Oliart AD, Romeu JR. Non-steroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Int Med. 1996;156:2433–9.
Pentheroudakis G, O’Neill VJ, Vasey P, Kaye SB. Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours. Report of two cases. Support Care Cancer. 2001;9(7):554–7.
Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Eng J Med. 1986;314:97–105.
Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003;23:460–4.
Ries F, Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis. 1986;8:368–79.
Condit PT, Chanes RE, Joel W. Renal toxicity of methotrexate. Cancer. 1969;23:126–31.
Wall SM, et al. Effective clearance of methotrexate using high-flux hemodialysis membranes. Am J Kidney Dis. 1996;28:846–54.
Walker RJ, Duggin GG. Drug nephrotoxicity. Annu Rev Pharmacol Toxicol. 1988;28:331–45.
Nagai J, Takano M. Review: Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokin. 2004;19:159–70.
Bieniasz M, Damogala P, Kwiatkowski A, et al. The assessment of residual kidney function after living donor nephrectomy. Transplant Proc. 2009;41:91–2.
Donckerwolcke RM, Coppes MJ. Adaptation of renal function after unilateral nephrectomy in children with renal tumours. Pediatr Nephrol. 2001;16:568–74.
Chapman D, Moore R, Klarenbach S, Braam B. Residual renal function after partial or radical nephrectomy for renal cell carcinoma. Can Urol Assoc J. 2010;4(5):337–43.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Thuraisingham, R. (2015). Renal Failure, Dialysis and Transplantation: In the Management of Renal Cell Carcinoma (Solitary Kidney and Bilateral Renal Tumours). In: Nargund, V., Raghavan, D., Sandler, H. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-0-85729-482-1_9
Download citation
DOI: https://doi.org/10.1007/978-0-85729-482-1_9
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-481-4
Online ISBN: 978-0-85729-482-1
eBook Packages: MedicineMedicine (R0)